This is great, thank you so much for all of this! This must have taken you an age to do, so once again, thank you very much. That is great that you are going back to work, but you better take it easy! And I hope that all goes well with work.

Best wishes,

Gavin

PS - Stay warm!!

Here is the breakdown for that  stats: for Nov1-Dec 18,2011(patient pop=22)
(# of patient information may not add up to 22 due to lack of data  provided)

GENDER: Female=14  ; MALE=8 
AGE:range=29-80(
           with 6 in the 50's; 2 in the 60's ;3 in the 70's ;
            1 in the 80's ; 6 in the<50's; 4 with no data.
DIAGNOSIS : intrahepatic CCA=9
                  ; extrahepatic CCA=9
                   not sure ICC or ECC.= 4
(18 of the patient DX alone in 2011,with 2 recurrences ;4 passed away)

CHEMO/RADIATION:
                  GEM/CIS = Gemcitabine+ciplatin  protocol= 9 patients.
                   GEMOX = Gemcitabine+oxaliplatin protocol=2 patients.
                   GEMOX+panitumimab = 1 patient.
                   GEM/CIS+everolimus  = 1 patient.
                   5FU protocol +?         = 1 patient.
                   Not sure about protocol = 4 patient.
Geographic LOCATION: UK=1 pt. Egypt=1 pt;Canada=3 pts ; rest=USA.

The observation::
1.The Male to Female ratio; usually is  more in man than women.
2.There are 6 patients in the <50 age group;a LARGE difference from the
   reports that I had studied;age between  50-70 is the prevalence group.
3.GEM/CIS is the most used protocol in both ICCA and ECCA. and just one      using 5 FU(including capecitabine);that is a bit surprise to me.

BTW, this is just a simple data collection in a random selected period with NO  STATISTICAL adjustments. 
God bless.

I will go back to work later this week, I may not have as much time as I want now to do things on the Web site along with all of you .
so, this is what I have done since Eli teach me to use the computer wisely.
God bless.

https://docs.google.com/document/d/1ix4 … CNTPk/edit